Michael Jay Ross - Oct 21, 2021 Form 4 Insider Report for Xilio Therapeutics, Inc. (XLO)

Role
Director
Signature
/s/ Chris Frankenfield, attorney-in-fact for Michael Ross
Stock symbol
XLO
Transactions as of
Oct 21, 2021
Transactions value $
$0
Form type
4
Date filed
10/25/2021, 05:18 PM
Next filing
Jun 17, 2022

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction XLO Stock Option (right to buy) Award $0 +26.4K $0.00 26.4K Oct 21, 2021 Common Stock 26.4K $16.00 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option award was granted on October 21, 2021 and will vest in three equal installments on October 21, 2022, October 21, 2023 and October 21, 2024.